NEW YORK, Jan 17 – A January 8 story about Packard BioScience has been clarified to reflect the company’s decision not to commercialize DNA chips, not microarrays, as previously stated. While the company has decided not to market DNA chips, Packard BioScience still intends to sell its microarray technology and to manufacture and sell protein chips.

The archived version of the story has been altered to more clearly reflect the company’s plans.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.